Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib might be used to treat hair loss.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.